Regeneron Pharmaceuticals (REGN) Cost of Revenue & History | Stock Alarm

Demo Sign up Log In

Regeneron Pharmaceuticals · Cost of Revenue

REGN Cost of Revenue

Latest reported$2.35Bperiod endingJun 30, 2026

REGN Cost of Revenue ($6.30M → $2.35B)

Annual cost of revenue

High-resolution chart · PNG

REGN cost of revenue history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Regeneron Pharmaceuticals Cost of Revenue — Annual fiscal periods (USD)
Period ending	Cost of Revenue (USD)
Dec 31, 2025	2,100,700,000
Dec 31, 2024	1,970,500,000
Dec 31, 2023	2,244,500,000
Dec 31, 2022	1,705,200,000
Dec 31, 2021	2,723,700,000
Dec 31, 2020	1,355,800,000
Dec 31, 2019	975,400,000
Dec 31, 2018	582,300,000
Dec 31, 2017	542,528,000
Dec 31, 2016	404,439,000
Dec 31, 2015	467,618,000
Dec 31, 2014	257,704,000
Dec 31, 2013	196,559,000
Dec 31, 2012	121,395,000
Dec 31, 2011	35,298,000
Dec 31, 2010	21,780,000
Dec 31, 2009	15,933,000
Dec 31, 2008	12,210,000
Dec 31, 2007	0
Dec 31, 2006	22,738,000
Dec 31, 2005	25,061,000
Dec 31, 2004	151,309,000
Dec 31, 2003	6,676,000
Dec 31, 2002	6,483,000
Dec 31, 2001	6,509,000
Dec 31, 2000	15,566,000
Dec 31, 1999	3,600,000
Dec 31, 1998	5,000,000
Dec 31, 1997	2,600,000
Dec 31, 1996	1,100,000
Dec 31, 1995	0
Dec 31, 1994	0
Dec 31, 1993	0
Dec 31, 1992	0
Dec 31, 1991	12,800,000
Dec 31, 1990	6,300,000

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.